Trials / Sponsors / Emergo Therapeutics, Inc.
Emergo Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness Influenza, Influenza -Like Illness | Phase 2 | 2020-12-14 |
| Completed | Norketotifen for the Treatment of Uncomplicated Influenza-like Illness Influenza -Like Illness | Phase 2 | 2019-10-21 |
| Completed | Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 2 | 2019-04-01 |
| Completed | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects Healthy Subjects | Phase 1 | 2018-10-15 |